Press "Enter" to skip to content

New patent for Sanofi-aventis Us drug ADMELOG SOLOSTAR

0
Listen to this article
Copyright © DrugPatentWatch. Originally published at New patent for Sanofi-aventis Us drug ADMELOG SOLOSTAR

Annual Drug Patent Expirations for ADMELOG+SOLOSTAR
Annual Drug Patent Expirations for ADMELOG+SOLOSTAR

Admelog Solostar is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.

Drug patent litigation for Admelog Solostar.

This drug has one hundred and forty-two patent family members in twenty-seven countries.

The generic ingredient in ADMELOG SOLOSTAR is insulin lispro. One supplier is listed for this compound. Additional details are available on the insulin lispro profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Sanofi-aventis Us drug ADMELOG SOLOSTAR
Do NOT follow this link or you will be banned from the site!